Rauno Naves

University of Helsinki — Finland

Medicine · Health Sciences

7h-index460citations16works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(16), COVID-19 Clinical Research Studies(6), Vaccine Coverage and Hesitancy(4), Animal Virus Infections Studies(4), Viral gastroenteritis research and epidemiology(3)

Publications16 total

Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine
BMC Infectious Diseases·2026Open Access
American mink as an animal model to study SARS-CoV-2 and vaccine response
2025· 1 citedOpen Access
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity
Frontiers in Immunology·2024· 5 citedOpen Access
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
Communications Medicine·2024· 14 citedOpen Access
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
Scientific Reports·2023· 9 citedOpen Access
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
Nature Communications·2023· 16 citedOpen Access
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
Research Square (Research Square)·2022Open Access
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
Nature Communications·2022· 62 citedOpen Access
Comparative analysis of BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 vaccine induced antibody responses and the 3rd BNT162b2 vaccine induced neutralizing antibodies against Delta and Omicron variants
2022· 1 citedOpen Access
Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2
Research Square (Research Square)·2021· 2 citedOpen Access
Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants
2021
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
Zurich Open Repository and Archive (University of Zurich)·2021· 6 citedOpen Access
A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2021
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
Nature Communications·2021· 294 citedOpen Access
A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics
The Journal of Infectious Diseases·2021· 35 citedOpen Access
COVID-19 mRNA vaccine induced antibody responses and neutralizing antibodies against three SARS-CoV-2 variants
Research Square (Research Square)·2021· 15 citedOpen Access

Frequent Co-authors

Arja Pasternack(16), Olli Ritvos(16), Pekka Kolehmainen(12), Pamela Österlund(12), Laura Kakkola(11), Ilkka Julkunen(11), Pinja Jalkanen(9), Paula A. Tähtinen(9), Sari Maljanen(9), Lauri Ivaska(9), Johanna Lempainen(9), Sisko Tauriainen(8), Olli Vapalahti(8), Moona Huttunen(7), Rickard Lundberg(7), Arttu Reinholm(7), Suvi Kuivanen(7), Hanni K. Häkkinen(6), Jussi Hepojoki(6), Anu Kantele(6)